Bharat Immunologicals (India) Buy or Sell Recommendation

Macroaxis provides Bharat Immunologicals Biologicals Corp Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bharat Immunologicals positions. The advice algorithm takes into account all of Bharat Immunologicals Biologicals Corp Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Bharat Immunologicals buy-and-hold prospective. Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Strong Sell'.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a mean deviation of 1.56, semi deviation of 0.0, standard deviation of 1.96, variance of 3.85, downside variance of 0.0 and semi variance of 0.0
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Bharat Immunologicals. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents .

Returns Distribution Density

Mean Return-0.34Value At Risk-2.5135
Potential Upside3.1579Standard Deviation1.9622
 Return Density 

Bharat Immunologicals Greeks

Alpha over DOW
βBeta against DOW=(1.35) 
Overall volatility
= 1.94 
 IrInformation ratio =(0.20) 

Bharat Immunologicals Volatility Alert

Bharat Immunologicals Biologicals Corp Ltd exhibits ver low volatility with skewness of 0.12 and kurtosis of -0.21. However, we advise investors to further study Bharat Immunologicals Biologicals Corp Ltd technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.50) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning(21.65) times40.69 times
Price to Book2.50 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.50 times0.72 times
Current Ratio1.69 times3.30 times
Earnings Per Share(1.24) times2.30 times
Number of Employees510.67 K
Market Capitalization1.16 B29.78 B
Z Score3.6708.73
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Currently Unavailable

Financial Leverage

Risk Adjusted Performance(0.04)
Market Risk Adjusted Performance0.2682
Mean Deviation1.56
Coefficient Of Variation(578.96)
Standard Deviation1.96
Information Ratio(0.20)
Jensen Alpha(0.30)
Total Risk Alpha(0.61)
Treynor Ratio0.2582
Maximum Drawdown7.58
Value At Risk(2.51)
Potential Upside3.16